PanGenomic https://validator.w3.org/feed/docs/rss2.html PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report Home- V1 Copies PanGenomic Health to Showcase Agenta Health at Vivacity Conference and Completes Warrant Financing PanGenomic Health Launches AGENTA Health eCommerce Platform and Provides Warrant Financing Update PanGenomic Health’s Subsidiary Mindleap Health Selects Hong Kong for its Health AI Centre Operations PanGenomic Health to Launch Real-World Evidence Platform for Complementary & Alternative Medicine through Mindleap Health Subsidiary Technology2 about PanGenomic Health Expands NaraCare.AI Platform with Launch of DNA Testing Program PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility PanGenomic Health Announces Changes to Board of Directors PanGenomic Health Announces Withdrawal from AQSE PanGenomic Health Announces Issuance of Management Cease Trade Order For Late Filing of Audited Annual Financial Statements PanGenomic Health Announces Plans to Settle Outstanding Debts of $1 Million in Private Placement Offering PanGenomic Health Closes Private Placement to Settle Outstanding Debts in the Amount of $1,075,000 PanGenomic Health Provides Update on Management Cease Trade Order PanGenomic Health Provides Update on Management Cease Trade Order PanGenomic Health Provides Update on Management Cease Trade Order PanGenomic Health Announces Financial Results for the 2023 Fiscal Year and Q1 2024 PanGenomic Health Announces Repricing of Outstanding Warrants Our Story Stock Information Contact Us Corporate governance PanGenomic Health Provides Corporate Update Financial & Regulatory Technology PanGenomic Health Announces AGM Result PanGenomic Health Announces Proposed Consolidation PanGenomic Health Announces Completion of Consolidation Home PanGenomic Health Announces Private Placement Offering for Gross Proceeds and to Settle Indebtedness of up to $750,000 PanGenomic Health Announces Intention to Reprice Outstanding Warrants PanGenomic Health Closes Private Placement Offering for Cash Proceeds and to Settle Indebtedness totalling $750,000 PanGenomic Health Announces Completion of Consolidation PanGenomic Health Announces Management Change PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE Shareholder Services Investor PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs investor PanGenomic Health Provides Update on Management Cease Trade Order PanGenomic Health Announces Issuance of Management Cease Trade Order for Late Filing of Audited Annual Financial Statements PanGenomic Health Provides Update on Management Cease Trade Order PanGenomic Health Announces Changes to Board of Directors and Management,Warrant Update and Stock Option Grants PanGenomic Health Announces Financial Results for the 2024 Fiscal Year PanGenomic Health Retains Investor Relations Firm and Provides Update on Warrant Expiration Date PanGenomic Health Provides Update on Management Cease Trade Order Contact Us